HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
Recruiting now · Phase 1
Conditions studied: Hiv, Alcohol Drinking, Fall, Cannabis Use
In brief
The focus of this pilot will be on falls and neurocognitive symptoms, and the impact of alcohol, cannabis use, and medications on these outcomes. The rationale is that alcohol use at any level may interact with neurocognitively active medications, alcohol, and cannabis use leading to falls and impaired cognition.
Key facts
- Study ID
- NCT06513819
- Run by
- Yale University
- People needed
- 100
- Starts
- 2025-01-15
- Expected to finish
- 2026-06-01
- Last updated by the study team
- 2026-01-15
Who can join
Age: 50 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- HIV+
- have visited a local VA site in within the past year
- had an AUDIT-C indicating current alcohol use
- taking 5 or more non-ART medications, including an NCAM (i.e., benzodiazepines, opioids, muscle relaxants, sleeping medication, and selective serotonin reuptake inhibitors)
You may not qualify if…
- Inpatient individuals
- Patients with an Alcohol Use Disorder (AUD) diagnosis in the past 12 months
- Patients who test positive on the Alcohol Symptom Checklist for moderate or severe AUD during the screening process
Where it is running
- VA Connecticut Healthcare System — West Haven, Connecticut, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.